BSE Live
Jan 23, 16:01Prev. Close
201.30
Open Price
203.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:53Prev. Close
207.16
Open Price
204.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
207.16 (2141)
| Key Financial Ratios of Viyash Scientific (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.88 | 0.31 | 16.77 | 0.00 | 0.34 | |
| Diluted EPS (Rs.) | 0.87 | 0.31 | 16.66 | 0.00 | 0.34 | |
| Cash EPS (Rs.) | 1.22 | 0.60 | 16.82 | 0.13 | 1.32 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 35.68 | 37.18 | 38.92 | 51.59 | 40.17 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 35.68 | 37.18 | 38.92 | 51.59 | 40.17 | |
| Dividend / Share(Rs.) | 0.00 | 0.20 | 0.20 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 9.15 | 6.73 | 4.35 | 3.72 | 16.65 | |
| PBDIT/Share (Rs.) | 1.48 | 0.67 | 0.24 | -0.47 | 2.03 | |
| PBIT/Share (Rs.) | 1.12 | 0.38 | 0.09 | -0.60 | 1.01 | |
| PBT/Share (Rs.) | 0.92 | 0.25 | 0.03 | -0.62 | 0.30 | |
| Net Profit/Share (Rs.) | 0.86 | 0.31 | 16.67 | 0.00 | 0.30 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 16.18 | 10.01 | 5.54 | -12.66 | 12.20 | |
| PBIT Margin (%) | 12.24 | 5.66 | 2.09 | -16.25 | 6.08 | |
| PBT Margin (%) | 10.03 | 3.73 | 0.62 | -16.71 | 1.80 | |
| Net Profit Margin (%) | 9.38 | 4.56 | 383.37 | -0.01 | 1.78 | |
| Return on Networth / Equity (%) | 2.40 | 0.82 | 42.84 | 0.00 | 0.73 | |
| Return on Capital Employed (%) | 3.07 | 1.00 | 0.23 | -1.15 | 0.71 | |
| Return on Assets (%) | 2.13 | 0.74 | 41.57 | 0.00 | 0.64 | |
| Total Debt/Equity (X) | 0.03 | 0.04 | 0.00 | 0.06 | 0.04 | |
| Asset Turnover Ratio (%) | 22.79 | 16.31 | 10.84 | 6.25 | 36.29 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.20 | 1.10 | 5.27 | 2.18 | 2.83 | |
| Quick Ratio (X) | 0.86 | 0.77 | 4.75 | 1.81 | 2.28 | |
| Inventory Turnover Ratio (X) | 7.24 | 6.56 | 7.66 | 1.45 | 7.06 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 1.19 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 1.18 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 98.81 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 98.82 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,955.67 | 1,811.76 | 1,883.46 | 3,214.67 | 3,521.80 | |
| EV/Net Operating Revenue (X) | 8.60 | 10.90 | 17.77 | 35.44 | 8.88 | |
| EV/EBITDA (X) | 53.15 | 108.85 | 320.15 | -279.76 | 72.73 | |
| MarketCap/Net Operating Revenue (X) | 8.49 | 10.67 | 17.80 | 34.62 | 8.79 | |
| Retention Ratios (%) | 0.00 | 0.00 | 98.80 | 0.00 | 0.00 | |
| Price/BV (X) | 2.18 | 1.93 | 1.99 | 2.50 | 3.64 | |
| Price/Net Operating Revenue | 8.49 | 10.67 | 17.80 | 34.62 | 8.79 | |
| Earnings Yield | 0.01 | 0.00 | 0.22 | 0.00 | 0.00 |
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y